These outcomes are attributable to mevalonate pathway inhibition, reduced endogenous CoQ10 synthesis, and weakened ATP generation [36]
The real question is whether patients will access these substances through licensed pharmacies, qualified prescribers, testing, traceability, and clinical oversight, or continue being pushed toward an unregulated research market
This finding provides significant clues to further reveal the mechanism of EBV reactivation, which is of potential clinical value for gaining insights into the early diagnosis and treatment of EBV-associated diseases
If it does not, the most defensible general approach is cold-chain handling: freezer storage for long-term dry powder, refrigerator storage for short-term reconstituted solution, and no casual room-temperature storage after mixing